MX2011010634A - Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. - Google Patents
Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa.Info
- Publication number
- MX2011010634A MX2011010634A MX2011010634A MX2011010634A MX2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A MX 2011010634 A MX2011010634 A MX 2011010634A
- Authority
- MX
- Mexico
- Prior art keywords
- monoclonal antibody
- human monoclonal
- lipopolysaccarides
- lps
- antibody specific
- Prior art date
Links
- 241000589517 Pseudomonas aeruginosa Species 0.000 title 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09005245 | 2009-04-09 | ||
| PCT/EP2010/002158 WO2010115606A1 (en) | 2009-04-09 | 2010-04-06 | Human monoclonal antibody specific for lipopolysaccarides (lps) of serotype iats 01 of pseudomonas aeruginosa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011010634A true MX2011010634A (es) | 2012-03-06 |
Family
ID=40934847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010634A MX2011010634A (es) | 2009-04-09 | 2010-04-06 | Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120114657A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2417157A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012523221A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20120016086A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102639562A (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI1013427A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2758081A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL215549A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011010634A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010115606A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130045207A1 (en) * | 2010-02-18 | 2013-02-21 | Symphogen A/S | Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| PL2718320T3 (pl) * | 2011-06-10 | 2018-06-29 | Medimmune Limited | Cząsteczki wiążące przeciwko PSL Pseudomonas i ich zastosowanie |
| KR102184343B1 (ko) | 2011-11-07 | 2020-11-30 | 메디뮨 엘엘씨 | 항슈도모나스 ｐｓｌ 및 ｐｃｒｖ 결합 분자를 이용한 병용 요법 |
| ES2981535T3 (es) | 2015-11-10 | 2024-10-09 | Visterra Inc | Conjugados de molécula de anticuerpo-fármaco que se unen específicamente al lipopolisacárido y usos de los mismos |
| JP7303110B2 (ja) | 2017-01-18 | 2023-07-04 | ビステラ， インコーポレイテッド | 抗体分子－薬物コンジュゲートおよびその使用 |
| JP2023521319A (ja) | 2020-04-03 | 2023-05-24 | ビステラ， インコーポレイテッド | 抗体分子－薬物コンジュゲートおよびその使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4834975A (en) | 1984-05-25 | 1989-05-30 | Genetics Corporation | Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
| US5955584A (en) * | 1986-03-31 | 1999-09-21 | Charter Ventures | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| ES2338105T3 (es) * | 2003-05-14 | 2010-05-04 | Kenta Biotech Ag | Anticuerpo monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 06 pseudomonas aeruginosa. |
| EP1690875A1 (en) * | 2005-02-14 | 2006-08-16 | Kenta Biotech AG | Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
-
2010
- 2010-04-06 BR BRPI1013427A patent/BRPI1013427A2/pt not_active IP Right Cessation
- 2010-04-06 KR KR1020117026384A patent/KR20120016086A/ko not_active Withdrawn
- 2010-04-06 MX MX2011010634A patent/MX2011010634A/es not_active Application Discontinuation
- 2010-04-06 JP JP2012503917A patent/JP2012523221A/ja not_active Withdrawn
- 2010-04-06 CA CA2758081A patent/CA2758081A1/en not_active Abandoned
- 2010-04-06 US US13/262,791 patent/US20120114657A1/en not_active Abandoned
- 2010-04-06 CN CN2010800256287A patent/CN102639562A/zh active Pending
- 2010-04-06 EP EP10713132A patent/EP2417157A1/en not_active Ceased
- 2010-04-06 WO PCT/EP2010/002158 patent/WO2010115606A1/en not_active Ceased
-
2011
- 2011-10-05 IL IL215549A patent/IL215549A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120114657A1 (en) | 2012-05-10 |
| CN102639562A (zh) | 2012-08-15 |
| WO2010115606A1 (en) | 2010-10-14 |
| CA2758081A1 (en) | 2010-10-14 |
| IL215549A0 (en) | 2011-12-29 |
| JP2012523221A (ja) | 2012-10-04 |
| KR20120016086A (ko) | 2012-02-22 |
| EP2417157A1 (en) | 2012-02-15 |
| BRPI1013427A2 (pt) | 2016-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201129381A (en) | Antibodies against human CSF-1R and uses thereof | |
| SG178886A1 (en) | Humanized anti-cdcp1 antibodies | |
| NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
| MX336682B (es) | Anticuerpos contra csf-1r humanos y usos de los mismos. | |
| CY1120413T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
| MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
| NZ594315A (en) | Antibody molecules having specificity for human ox40 | |
| UA101487C2 (en) | Humanized b-ly1 antibody formulation | |
| IN2012DN00797A (cg-RX-API-DMAC7.html) | ||
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| MY178926A (en) | Bispecific anti-vegf/anti-ang-2 antibodies | |
| MY160736A (en) | Bivalent, bispecific antibodies | |
| MX2010004482A (es) | Anticuerpos anti-proteina g vsr. | |
| WO2009083009A3 (en) | Monoclonal antibodies against cd32b | |
| UA109658C2 (xx) | Антитіло проти cgrp | |
| WO2009061996A3 (en) | Antibodies that bind human dendritic and epithelial cell 205 (dec-205) | |
| EA201000903A1 (ru) | Антитела к pcrv-антигену pseudomonas aeruginosa | |
| MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
| WO2011147982A3 (en) | Monoclonal antibodies against her2 epitope | |
| AU2016219704A1 (en) | Anti-Notch1 antibodies | |
| MX2011010634A (es) | Anticuerpos monoclonal humano especifico para lipopolisacaridos (lps) de serotipo iats 01 de pseudomonas aeruginosa. | |
| EP3492101A3 (en) | Agents for influenza neutralization | |
| IL184774A0 (en) | Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats 011 serotype | |
| MX347978B (es) | Uso de los anticuerpos anti-il-17a y anti-il-17f en el tratamiento de la resistentes a insulina. | |
| WO2009035959A3 (en) | Radiofluorination methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |